MedTrace Logo

Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes

NCT05057299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2021-09-27

No results posted yet for this study

Summary

Patients with extramedullary leukemia were identified over 10 years (January 2003 to September 2019). Clinicopathological,genetic-molecular features were identified and survival outcomes were studied and analyzed.

Conditions

Interventions

OTHER

retrospective data analysis

chart review, analysis and reporting outcomes

Sponsors & Collaborators

  • King Hussein Cancer Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05057299 on ClinicalTrials.gov